Leslie Smith
Family · Bellevue, WANPI 1033416672
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 27.4% of the total. Reporting peaked in 2022 at $631 and has fallen 88.9% since, to $70 in 2023.
Across 62 payments — averaging $20.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$353
- Vanda Pharmaceuticals Inc.$117
- Novo Nordisk$113
- Lilly USA, LLC$101
- Johnson & Johnson$83
- Biohaven Pharmaceuticals, Inc.$66
- plus $456 from 17 others
What the payments were for
- Food & beverage$1,288100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $353 |
| Vanda Pharmaceuticals Inc. | 4 | $117 |
| Novo Nordisk | 5 | $113 |
| Lilly USA, LLC | 6 | $101 |
| Johnson & Johnson | 3 | $83 |
| Biohaven Pharmaceuticals, Inc. | 3 | $66 |
| Kowa Pharmaceuticals America, Inc. | 3 | $61 |
| Agile Therapeutics, Inc. | 2 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $42 |
| Bausch Health US, LLC | 2 | $41 |
| Astellas Pharma US Inc | 2 | $35 |
| Amgen | 1 | $31 |
| Abbott | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| GSK | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Gilead | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Avion Pharmaceuticals | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Merck | 1 | $12 |
How this compares
$1,288 in reported general payments places this provider in the 80th percentile of 1,706 family providers in Washington.
Other family in Bellevue
- Hye-Jin GehringBellevue$30K
- Yi LiuBellevue$5K
- Sharla PetersonKenmore$192K
- Zelda SwainSpokane$83K
- Savannah MorganRenton$76K
- Kevan PettersonSeattle$56K
- Kelly McFeeSunnyside$42K
- Cheryl SomersSpokane$31K
- Kaitlin BrasierSeattle$29K
- Karen JohnsonSeattle$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.